Claims for Patent: 11,628,088
✉ Email this page to a colleague
Summary for Patent: 11,628,088
| Title: | Ultrasonically detectable intrauterine system and a method for enhancing ultrasound detection |
| Abstract: | The present invention relates to ultrasonically detectable intrauterine systems and to a method for enhancing ultrasound detection of these systems. An intrauterine system having an inert metal coating on at least part of the body of the intrauterine system or at least one inert metal clip, pin, ring or sleeve fixedly positioned on the body of the intrauterine system is described. |
| Inventor(s): | Taina Tjäder, Sara Heinonen |
| Assignee: | Bayer Oy |
| Application Number: | US14/569,616 |
| Patent Claims: |
1. An ultrasonically detectable intrauterine system (IUS) for long-term insertion into a uterine cavity comprising: a vertical arm having an upper end and a lower end; horizontal arms extending from the upper end of the vertical arm; a hormone-containing capsule mounted on the vertical arm; and an image enhancing structure adapted to improve ultrasound imaging of the IUS, wherein the image enhancing structure comprises an inert metal ring, wherein: the inert metal ring is composed of silver and has a width of 0.2 mm to 1 mm; the inert metal ring surrounds the upper end of the vertical arm and is at least partially embedded in the upper end of the vertical arm; and the inert metal ring does not comprise an active ingredient. 2. The IUS of claim 1, further comprising at least two locking structures to keep the hormone-containing capsule in correct position during insertion, use and removal of the IUS. 3. The IUS of claim 1 wherein: the hormone-containing capsule is a hormone-elastomer capsule that regulates a release of levonorgestrel and the inert metal ring comprises a double ring that surrounds the upper end of the vertical arm. 4. The IUS of claim 1, wherein the inert metal ring comprises 0.5 mm thick wire. 5. The IUS of claim 1, wherein the inert metal ring is disposed within a 0.25 mm deep channel formed in the upper end of the vertical arm. 6. A method to form an intrauterine system (IUS) with improved visibility within a uterine cavity in an ultrasound examination, the method comprising: forming a vertical arm of the IUS with a medicated capsule mounted thereto; forming a first portion of one of an upper end of the vertical arm, a lower end of the vertical arm, and an end of a horizontal arm extending from the upper end of the vertical arm; and surrounding the upper end of the vertical arm with an inert metal ring, wherein the inert metal ring is composed of silver, does not comprise an active ingredient, has a width of 0.2 to 1 mm, and is at least partially embedded in the upper end of the vertical arm. 7. The method of claim 6, further comprising forming at least two locking structures on the vertical arm to keep the medicated capsule in correct position during insertion, use and removal of the IUS. 8. The method of claim 6, further comprising: forming a channel in the upper end of the vertical arm, wherein the channel is 0.25 mm; and disposing the inert metal ring within the channel to partially embed the inert metal ring within the upper end of the vertical arm. 9. The method of claim 6, further comprising: surrounding the lower end of the vertical arm or the end of the horizontal arm with a second inert metal ring, wherein the second inert metal ring is composed of silver. 10. The method of claim 6, wherein the medicated capsule is a hormone-elastomer capsule that regulates a release of levonorgestrel. 11. The IUS of claim 1 wherein the hormone-containing capsule is a hormone-elastomer capsule that regulates a release of levonorgestrel. 12. A method for improving the visualization of an intrauterine system within the uterine cavity in an ultrasound examination comprising providing an IUS according to claim 1, and inserting the IUS into the uterine cavity and examining the position of the IUS within the uterine cavity in an ultrasound examination. 13. The IUS of claim 1, wherein the inert metal ring is composed of a silver wire. 14. The IUS of claim 1 comprising only one inert metal ring. 15. The method of claim 6 comprising only one inert metal ring. 16. The IUS of claim 1, wherein the IUS is a hormonal device only, wherein the hormone-containing capsule comprises the only active hormonal ingredient. 17. The method of claim 6, wherein the IUS is a hormonal device only, wherein the hormone-containing capsule comprises the only active hormonal ingredient. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
